MadSci Network: Neuroscience |
For this question I had to ask a few other neurologist and neuroscientists. This is the combined response from three people. First, the question, "Can the myelin sheath be damaged over time from radioactive isotopes?" is different than the one really asked " is it possible that this dye could cause a problem?" Most myelograms done years ago were with a contrast dye called pantopaque, which, to my knowledge, is neither radioactive nor neurotoxic. (one person's view). However, there are some reports about toxic effects of this dye and I have provided the references below as well as abstracts in 2 cases. Some of these articles might be hard to obtain the full report and read since one is in Portuguese and the other in German. So a quick reply, is that there is generally no problem from having the contrast dye remain in the body. The more involved answer begins with finding out with certainty what is the name of the contrast material the individual received? Likely, the myelogram reports would have this information. Next, would be a review of literature concerning the agent used to see if there are any reports of problems associated with it. A neuroradiologist who has been in practice for at least 10 years would probably be familiar with literature concerning older myelogram dyes. Report #1 Constrictive arachnoiditis after pantopaque myelography causing syringomyelia and paraparesis: case report Arq Neuropsiquiatr 2001 Sep;59(3-A):619-22 [Article in Portuguese] Silva JA, Taricco MA, Brito JC, Neves VD, Farias RL. Servico de Neurologia e Neurocirurgia, Hospital Santa Isabel, Joao Pessoa, PB, Brasil. We present an unusual case of thoracic constrictive arachnoiditis after pantopaque myelography, used 10 years before in the diagnosis of intradural arachnoid cyst. Report #2 Symptomatic pulmonary complications from liquid acrylate embolization of brain arteriovenous malformations. AJNR Am J Neuroradiol 1995 Jan;16(1):19-26 Pelz DM, Lownie SP, Fox AJ, Hutton LC. Department of Diagnostic Radiology, University Hospital, University of Western Ontario, Canada. PURPOSE: To describe symptomatic pulmonary emboli from brain arteriovenous malformation embolization with liquid acrylates and to analyze the reasons for these complications and describe preventive techniques. METHODS: The clinical records of 182 patients embolized with acrylate glue since 1978 for treatment of brain AVMs were searched for evidence of symptomatic pulmonary complications. Originally iso-butyl-2-cyanoacrylate and more recently n-butyl-2-cyanoacrylate were used in all patients. Arteriovenous malformation morphology, amounts and techniques of glue injection, and clinical and radiologic investigations in the symptomatic patients were recorded. RESULTS: Three patients had pulmonary symptoms within 48 hours of glue injection. One patient with a left frontal arteriovenous malformation had embolization with an isobutyl-2- cyanoacrylate/pantopaque/acetic acid mixture; severe pleuritic chest pain developed 2 days later. One patient with a left temporal and one with a left cerebellar arteriovenous malformation had embolization with n-butyl-2- cyanoacrylate/lipiodol mixtures; a cough, pleuritic chest pain, and bloody sputum developed in both within 24 hours. Two patients experienced a significant drop in PO2. No flow-arrest techniques were used for any of the injections in these three patients. All patients demonstrated significant changes on chest x-ray and CT chest examinations. All were treated conservatively and recovered spontaneously. CONCLUSIONS: Symptomatic pulmonary complications can occur after acrylate glue injection, particularly when delivery systems without flow arrest are used in high-flow vascular brain lesions. Techniques using acetic acid to delay polymerization time and "sandwich" techniques in which glue is pushed with dextrose are also more susceptible to this complication. Report # 3 Complications following myelography with positive contrast media (Pantopaque, Amipaque). Pathomorphologic findings in 2 fatal cases Zentralbl Neurochir 1985;46(2):141-50 [Article in German] Baessler B, Lahl R. It is reported on three patients which suffered from severe side effects after cervical myelography using Amipaque (cases 1 and 3) and Pantopaque (case 2). In 2 cases death occurred after 13 days (case 2) respectively 17 days (case 3). Worsening of the clinical symptoms appeared in all cases within four days after myelography. In the first 2 cases inflammatory alterations prevailed whereas in the third case complications probably based on mechanical irritations of nerval and vascular structures. In the 2 lethal cases autopsy offered a prostatic cancer with vertebral and intraspinal metastases respectively syringobulbia and cervical syringomyelia beside an ependymoma of the cervical spinal cord as incurrable complaints. The various side effects and complications after myelography using positive contrast media as well as their causes are discussed. end of file>>>>>>>>>>>>>>>>>>
Try the links in the MadSci Library for more information on Neuroscience.